Exposure paradigm of fluoxetine impacted the Faxonius virilis agonistic behavior differently

Pharmaceutically active compounds are major contaminants of aquatic environments. The effects on aquatic organisms have been assessed mostly through eco-toxicological tests performed using static exposure systems or flow through systems with constant concentrations. Yet, constant concentration exposures ignore the spatio-temporal dynamics of chemicals in flowing environments. In dynamic systems, a chemical's effect on an organism will vary due to fluctuations in the frequency, magnitude, and duration of the chemical concentration within the plume, which develops due to turbulence interacting with the geomorphology of habitat. The aim of this study was to analyze how different exposure dynamics to the antidepressant fluoxetine might alter the agonistic behavior of aquatic organisms. Male crayfishes, Faxonius virilis, were subjected to 23 h exposures at different concentrations of fluoxetine (control, 0.05, 0.5, 1, 10 and 100 μg/l) in both static and dynamic mesocosm systems. After exposure, size-matched crayfishes, from the same exposure system and fluoxetine concentration, underwent a fifteen minute fight trial. The aggressive intensities and duration of agonistic interactions were quantified. The time spent performing a tailflip was significantly longer for fluoxetine concentrations of 1, 10, 100 μg/l in the static exposure than in the dynamic exposure. On other hand, the time spent at higher intensities and the time to escalate to the highest intensity of interactions in control treatments were significantly lower in the dynamic exposure than in the static exposure. Whereas, in elevated fluoxetine concentrations, these times were significantly higher in the dynamic than in static treatments. Therefore, we could conclude that the fight dynamics and duration of agonistic behavior in crayfish were affected by static and dynamic exposure paradigms differently. Despite these behavioral changes, serotonin levels in fluoxetine-exposed crayfish did not differ significantly between exposure paradigms. Future research should incorporate different exposure methods that more accurately represent chemical exposure in natural habitats.

Occurrence, bioaccumulation, and trophic magnification of pharmaceutically active compounds in Taihu Lake, China

The occurrence, bioaccumulation, and trophic magnification of pharmaceutically active compounds, (PhACs) including antibiotics (roxithromycin and erythromycin), non-steroidal anti-inflammatory drugs (ibuprofen and diclofenac), a non-selective β-adrenoceptor blocker (propranolol), an antiepileptic drug (carbamazepine), and steroid estrogens (17β-estradiol and 17α-ethynylestradiol), were investigated in Taihu Lake, China. All eight PhACs were widely detected in surface water and sediment samples with maximal concentrations in the range of 8.74-118 ng L(-1) and 0.78-42.5 ng g(-1) dry weight (dw), respectively. The investigated organisms in the natural freshwater food web in Taihu Lake included phytoplankton, zooplankton, zoobenthos, and fish, and the maximal concentrations of target compounds in these biota samples ranged from 0.65 to 132 ng g(-1) dw. Bioaccumulation factors (BAFs) for all target PhACs were lower than 1000 L kg(-1), suggesting their low bioaccumulation potential in aquatic organisms from Taihu Lake. Trophic magnification factors (TMFs) were estimated at 1.11 for roxithromycin, 0.31 for propranolol, and 1.06 for diclofenac, indicating none of these PhACs underwent trophic magnification in this freshwater food web.

The adsorption of pharmaceutically active compounds from aqueous solutions onto activated carbons

In this study, the adsorption of pharmaceutically active compounds - salicylic acid, acetylsalicylic acid, atenolol and diclofenac-Na onto activated carbons has been studied. Three different commercial activated carbons, possessing ∼650, 900 or 1500m(2)g(-1) surface areas were used as solid adsorbents. These materials were fully characterized - their textural, surface features and points of zero charge have been determined. The adsorption was studied from aqueous solutions at 303K using batch adsorption experiments and titration microcalorimetry, which was employed in order to obtain the heats evolved as a result of adsorption. The maximal adsorption capacities of investigated solids for all target pharmaceuticals are in the range of 10(-4)molg(-1). The obtained maximal retention capacities are correlated with the textural properties of applied activated carbon. The roles of acid/base features of activated carbons and of molecular structures of adsorbate molecules have been discussed. The obtained results enabled to estimate the possibility to use the activated carbons in the removal of pharmaceuticals by adsorption.

Occurrence and fate of pharmaceutically active compounds in the largest municipal wastewater treatment plant in Southwest China: mass balance analysis and consumption back-calculated model

The occurrence and fate of twenty-one pharmaceutically active compounds (PhACs) were investigated in different steps of the largest wastewater treatment plant (WWTP) in Southwest China. Concentrations of these PhACs were determined in both wastewater and sludge phases by a high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Results showed that 21 target PhACs were present in wastewater and 18 in sludge. The calculated total mass load of PhACs per capita to the influent, the receiving water and sludge were 4.95mgd(-1)person(-1), 889.94μgd(-1)person(-1) and 78.57μgd(-1)person(-1), respectively. The overall removal efficiency of the individual PhACs ranged from "negative removal" to almost complete removal. Mass balance analysis revealed that biodegradation is believed to be the predominant removal mechanism, and sorption onto sludge was a relevant removal pathway for quinolone antibiotics, azithromycin and simvastatin, accounting for 9.35-26.96% of the initial loadings. However, the sorption of the other selected PhACs was negligible. The overall pharmaceutical consumption in Chongqing, China, was back-calculated based on influent concentration by considering the pharmacokinetics of PhACs in humans. The back-estimated usage was in good agreement with usage of ofloxacin (agreement ratio: 72.5%). However, the back-estimated usage of PhACs requires further verification. Generally, the average influent mass loads and back-calculated annual per capita consumption of the selected antibiotics were comparable to or higher than those reported in developed countries, while the case of other target PhACs was opposite.